Dr Rebecca Winter
Deputy Head, Justice Health
Working groups

Background
Rebecca Winter has over 15 years of experience in public health research. Primarily, she has worked on studies relating to risk behaviours and risk groups relating to communicable disease transmission, with a particular interest in drug user and justice-involved populations.
Rebecca completed her doctoral studies on injecting drug-related harms among prisoners and ex-prisoners in 2016.
Qualifications
- 2017: PhD, Monash University, Australia
- 2010: MPH, Latrobe University, Australia
- 2002: BA, Latrobe University, Australia
Appointments
- Burnet Fellow; Honorary Research Fellow, St Vincent's Hospital Melbourne
- Adjunct Research Fellow, School of Public Health and Preventive Medicine, Monash University
Awards
- 2016: Burnet Institute Travel Award
- 2013: ICAAP (International Conference on AIDS in Asia and the Pacific) student scholarship, Bangkok, Thailand
- 2012: NIDA Conference Scholarship, Academic and Health Policy Conference on Correctional Health, Atlanta, GA, USA
- 2010: National Health and Medical Research Council (NHMRC) PhD Scholarship, Dora Lush Public Health Scholarship
Positions
- 2022: Deputy Head Justice Health Group
- 2022: Research Fellow, Burnet Institute
- 2020: Senior Research Officer, Burnet Institute
- 2016: Research Officer, Burnet Institute
- 2011-2016: PhD candidate, Monash University and Burnet Institute
- 2005-2010: Research Assistant, Burnet Institute
Reports and other work
-
Technical review of hepatitis C health promotion resources.
The hepatitis C virus impacts approximately 200,000 Australians, according to the National Centre in HIV Epidemiology and Clinical Research (NCHECR) in 2010. Presently, there is no vaccine available to prevent transmission of the virus. In New South Wales alone, there were 3,950 new diagnoses of hepatitis C infection in 2009, as reported by the NCHECR.
Technical review of hepatitis C health promotion resources.
Burnet publications
View 42 moreThe hepatitis C cascade of care for opioid agonist therapy recipients in Australia
Clinical Infectious Diseases
S. Griffin et al
"Quick, simple, and friendly": Understanding the acceptability and accessibility of a nurse and peer-led, mobile model of hepatitis C care adjacent to community corrections in Australia
International Journal of Drug Policy
S. Griffin et al
The costs and benefits of a prison needle and syringe program in Australia, 2025–30: a modelling study
The Medical Journal of Australia
Farah Houdroge et al
Current projects
Achieving the final phases of hepatitis C elimination using innovative models of care
We're identifying innovative models of care so that no-one misses out on HCV care in Australia and globally.

How stable housing can support people who use drugs (HOUSED)
Australia is experiencing a housing crisis, and people who use drugs are being left behind. To address this, we're analysing the social, economic and health benefits of stable housing for people who use drugs.
The C No More Project: Community corrections Nurse-led Model of care to Eliminate hepatitis C
This study will offer free hepatitis C testing and treatment to people in community corrections and assess the effectiveness of the model of care.
Past projects
View 3 more
The elimination of hepatitis C as a global public health threat
This project addresses critical knowledge gaps in Australian and global efforts to eliminate hepatitis C as a public health threat by 2030.

Eliminate C (EC) Victoria partnership
A partnership aimed at increasing hepatitis C treatment uptake among people who inject drugs (PWID) using nurse-led models of care in community and prison settings.
Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT
This study provided evidence on whether a supervised drug consumption room (or rooms) is suited to the ACT context.